@article{ref1,
title="Attempted suicide with the SGLT2 inhibitor empagliflozin saves patient's life",
journal="Diabetologe",
year="2018",
author="Schneider, A. and Lengenfelder, B.",
volume="14",
number="2",
pages="99-100",
abstract="A suicide attempt by a 74-year-old female patient by means of an overdose of the SGLT2 inhibitor empagliflozin is reported. Laboratory tests could not detect any substantial side effects of empagliflozin, such as hypoglycemia or imbalances in the acid-base metabolism. The patient developed ventricular fibrillation in the further course. Short-term resuscitation and defibrillation was necessary, followed by coronary angiography, which revealed three-vessel coronary artery disease. This was treated by PCI and stenting. Afterwards, she was transferred to a rehabilitation centre. Presumably, the failed suicide attempt with empagliflozin ultimately saved the patient's life. © 2018, Springer Medizin Verlag GmbH, ein Teil von Springer Nature.<p /><p>Language: de</p>",
language="de",
issn="1860-9716",
doi="10.1007/s11428-018-0310-6",
url="http://dx.doi.org/10.1007/s11428-018-0310-6"
}